Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) EBT Margin: 2024-2025

Historic EBT Margin for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -357.19%.

  • Kura Oncology's EBT Margin fell 1356204.00% to -357.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -431.50%, marking a year-over-year change of. This contributed to the annual value of -319.15% for FY2024, which is 1017266.00% down from last year.
  • Kura Oncology's EBT Margin amounted to -357.19% in Q3 2025, which was up 17.42% from -432.51% recorded in Q2 2025.
  • Kura Oncology's 5-year EBT Margin high stood at 13,204.85% for Q3 2024, and its period low was -432.51% during Q2 2025.
  • For the 2-year period, Kura Oncology's EBT Margin averaged around 5,891.76%, with its median value being 4,267.74% (2024).
  • Data for Kura Oncology's EBT Margin shows a maximum YoY plummeted of 1,356,204bps (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's EBT Margin (Quarterly) stood at 4,267.74% in 2024, then plummeted by 1,356,204bps to -357.19% in 2025.
  • Its EBT Margin was -357.19% in Q3 2025, compared to -432.51% in Q2 2025 and -405.46% in Q1 2025.